References
- Office of the Assistant Secretary for Public Affairs. What is the U.S. opioid epidemic? [Internet]. HHS.gov. https://plus.google.com/+HHS. 2017. [cited 2021 Feb 26]. Available from: https://web.archive.org/web/20220324053428/https://www.hhs.gov/opioids/about-the-epidemic/index.html
- Understanding the Epidemic | Drug Overdose | CDC Injury Center [Internet]. 2020. [cited 2021 Feb 26]. Available from: https://www.cdc.gov/drugoverdose/epidemic/index.html.
- Smyth B, Hoffman V, Fan J, Hser YI. Years of potential life lost among heroin addicts 33 years after treatment. Prev Med. 2007;44(4):369–74. doi:10.1016/j.ypmed.2006.10.003.
- O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700—10 states, July–December 2016. MMWR Morb Mortal Wkly Rep. 2017;66:1197–202. doi:10.15585/mmwr.mm6643e1.
- O’Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region—United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017; 66:897–903. doi:10.15585/mmwr.mm6634a.
- Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deaths. JAMA. 2017;318(23):2295–6. doi:10.1001/jama.2017.15971.
- Ciccarone D. Editorial for “US heroin in transition: supply changes, fentanyl adulteration and consequences” IJDP special section. Int J Drug Policy. 2017;46:107–11. doi:10.1016/j.drugpo.2017.06.010.
- Park JN, Rashidi E, Foti K, Zoorob M, Sherman S, Alexander GC. Fentanyl and fentanyl analogs in the illicit stimulant supply: results from U.S. drug seizure data, 2011–2016. Drug Alcohol Depend. 2021;218:108416. doi:10.1016/j.drugalcdep.2020.108416.
- Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose data [Internet]. National Center for Health Statistics; 2022. May [cited 2022 May 31]. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
- Klebacher R, Harris MI, Ariyaprakai N, Tagore A, Robbins V, Dudley LS, Bauter R, Koneru S, Hill RD, Wasserman E, et al. Incidence of naloxone redosing in the age of the new opioid epidemic. Prehosp Emerg Care. 2017;21(6):682–7. doi:10.1080/10903127.2017.1335818.
- Cash RE, Kinsman J, Crowe RP, Rivard MK, Faul M, Panchal AR. Naloxone administration frequency during emergency medical service events—United States, 2012–2016. MMWR Morb Mortal Wkly Rep. 2018;67(31):850–3. doi:10.15585/mmwr.mm6731a2.
- Gulec N, Lahey J, Suozzi JC, Sholl M, MacLean CD, Wolfson DL. Basic and advanced EMS providers are equally effective in naloxone administration for opioid overdose in Northern New England. Prehosp Emerg Care. 2018;22(2):163–9. doi:10.1080/10903127.2017.1371262.
- Davis CS, Ruiz S, Glynn P, Picariello G, Walley AY. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health. 2014;104(8):e7–9. doi:10.2105/AJPH.2014.302062.
- Connecticut Department of Public Health. Change to EMR, EMT, AEMT Scope of Practice - Administration of Naloxone [Internet]. 2014. [cited 2022 Mar 27]. Available from: https://portal.ct.gov/-/media/Departments-and-Agencies/DPH/dph/ems/pdf/Communication_Statements/201406ChangetoEMREMTAEMTScopeofPracticeAdministrationofNaloxonepdf.pdf
- Nugent K, Matthews P, Gissendaner J, Papas M, Occident D, Patel A, Johnson M, Megargel RE, Nomura JT. A comparison of efficacy of treatment and time to administration of naloxone by BLS and ALS providers. Prehosp Disaster Med. 2019;34(4):350–5. doi:10.1017/S1049023X19004527.
- State of Connecticut, Office of Emergency Medical Services. OEMS Communications Statement 17-06. 2017 [cited 2021 Mar 18]. Available from: https://portal.ct.gov/-/media/Departments-and-Agencies/DPH/dph/ems/pdf/Communication_Statements/2017_07_12_OEMS_COMMS_17-06_NALOXONE_4_MG_AUTH_FINAL.pdf
- Ruscio J. Constructing confidence intervals for Spearman’s rank correlation with ordinal data: a simulation study comparing analytic and bootstrap methods. J Mod App Stat Meth. [Internet] 2008;7(2):416–34. Available from: https://digitalcommons.wayne.edu/jmasm/vol7/iss2/7 doi:10.22237/jmasm/1225512360.
- Moss RB, Carlo DJ. Higher doses of naloxone are needed in the synthetic opioid era. Subst Abuse Treat Prev Policy. 2019;14(1):6. doi:10.1186/s13011-019-0195-4.
- Abdelal R, Banerjee AR, Carlberg-Racich S, Darwaza N, Ito D, Epstein J. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature. Subst Abus. 2022;43(1):774–84. doi:10.1080/08897077.2021.2010252.
- Strickland JC, Marks KR, Smith KE, Ellis JD, Hobelmann JG, Huhn AS. Patient perceptions of higher-dose naloxone nasal spray for opioid overdose. Int J Drug Policy. 2022;106:103751. doi:10.1016/j.drugpo.2022.103751.
- Wightman RS, Nelson LS. Naloxone dosing in the era of fentanyl: the path widens by traveling down it. Ann Emerg Med. [Internet] 2022. May 26 [cited 2022 May 30]. Available from: https://www.annemergmed.com/article/S0196-0644(22)00263-3/fulltext#%20
- Farkas A, Westover R, Pizon AF, Lynch M, Martin-Gill C. Outcomes following naloxone administration by bystanders and first responders. Prehosp Emerg Care. 2021;25(6):740–6. doi:10.1080/10903127.2021.1918299.
- Sellberg M. Combatting the EMS shortage with data. J Emerg Med Serv. [Internet]. 2022. Available from: https://www.jems.com/administration-and-leadership/combatting-the-ems-shortage-with-data/
- COVID-19 Town Halls. National Association of EMS Physicians. [Internet]. [cited 2023 Feb 2]. Available from: https://naemsp.org/resources/covid-19-resources/covid-19-town-halls/#Overcrowding
- Janke AT, Melnick ER, Venkatesh AK. Hospital occupancy and emergency department boarding during the COVID-19 pandemic. JAMA Netw Open. 2022;5(9):e2233964. doi:10.1001/jamanetworkopen.2022.33964.
- Scharf BM, Sabat DJ, Brothers JM, Margolis AM, Levy MJ. Best practices for a novel EMS-based naloxone leave behind program. Prehosp Emerg Care. 2021;25(3):418–26. doi:10.1080/10903127.2020.1771490.
- Rando J, Broering D, Olson JE, Marco C, Evans SB. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. Am J Emerg Med. 2015;33(9):1201–4. doi:10.1016/j.ajem.2015.05.022.
- Bennett AS, Bell A, Doe-Simkins M, Elliott L, Pouget E, Davis C. From peers to lay bystanders: Findings from a decade of naloxone distribution in Pittsburgh, PA. J Psychoactive Drugs. 2018;50(3):240–6. doi:10.1080/02791072.2018.1430409.
- Giglio RE, Li G, DiMaggio CJ. Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj Epidemiol. 2015 May 22;2(1):10. doi:10.1186/s40621-015-0041-8.
- Keane C, Egan JE, Hawk M. Effects of naloxone distribution to likely bystanders: Results of an agent-based model. Int J Drug Policy. 2018;55:61–9. doi:10.1016/j.drugpo.2018.02.008.
- Canning P, Doyon S, Ali S, Logan SB, Alter A, Hart K, Coler R, Kamin R, Wolf SC, Soto K, et al. Using surveillance with near–real-time alerts during a cluster of overdoses from fentanyl-contaminated crack cocaine, Connecticut, June 2019. Public Health Rep. 2021;136(1_suppl):18S–23S. doi:10.1177/00333549211015662.
- Isoardi KZ, Parker L, Harris K, Rashford S, Isbister GK. Acute opioid withdrawal following intramuscular administration of naloxone 1.6 mg: a prospective out-of-hospital series. Ann Emerg Med. 2022;80 Apr 29 [cited 2022 Jun 1]; Available from(2):120–6. [Internet] https://www.sciencedirect.com/science/article/pii/S0196064422001706 doi:10.1016/j.annemergmed.2022.03.004.
- Herring AA. Postoverdose initiation of buprenorphine after naloxone-precipitated withdrawal is encouraged as a standard practice in the California Bridge Network of Hospitals. Ann Emerg Med. 2020; Apr 175(4):552–3.
- KBEMS 8/11/22 Meeting Minutes - Motion to amend 202 KAR 7:701 Section (2) carried [Internet]. [cited 2022 Dec 10]. Available from: https://www.dropbox.com/sh/nd6dxsy5ilb4nfg/AADiQ1JU1XfymS7-3MOwnb68a?dl=0